#1 Clinical Trials Search in Europe

Explore popular drugs in clinical trials

Check which drugs are currently being frequently studied.

See also our rare diseases glossary and popular diseases list.

Starting by letter

To open the drugs glossary, select a letter from the list below.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All drugs

Most popular drugs

The list below features the most popular substances currently involved in ongoing clinical trials.

Drug Trials
Pembrolizumab 446
Sodium Chloride 411
Carboplatin 337
Cisplatin 282
Paclitaxel 250
Fluorouracil 232
Oxaliplatin 223
Nivolumab 209
Dexamethasone 204
Rituximab 194
Cyclophosphamide 186
Bevacizumab 161
Durvalumab 161
Capecitabine 156
Paracetamol 155
Atezolizumab 146
Docetaxel 128
Prednisone 127
Tocilizumab 124
Prednisolone 121
Gemcitabine 117
Venetoclax 116
Pemetrexed 114
Mycophenolate Mofetil 114
Etoposide 114
Doxorubicin Hydrochloride 108
Infliximab 98
Lenalidomide 98
Ipilimumab 90
Folinic Acid 89
Acetylsalicylic Acid 88
Semaglutide 88
Paclitaxel Albumin-Bound 84
Placebo 84
Cytarabine 79
Daratumumab 79
Calcium Folinate 78
Methotrexate 78
Fludarabine Phosphate 77
Letrozole 72
Bortezomib 71
Olaparib 70
Gemcitabine Hydrochloride 69
Obinutuzumab 67
Dapagliflozin 66
Azacitidine 66
Trastuzumab 65
Cetuximab 64
Tacrolimus 63
Fulvestrant 62
Lenvatinib 62
Methylprednisolone 61
Irinotecan 61
Irinotecan Hydrochloride Trihydrate 59
Temozolomide 59
Cemiplimab 57
Vincristine Sulfate 57
Trastuzumab Deruxtecan 53
Enzalutamide 51
Lidocaine Hydrochloride Monohydrate 50
Apixaban 50
Betamethasone Sodium Phosphate 50
Dexamethasone Sodium Phosphate 49
Codeine Phosphate 49
Amoxicillin 47
Buclizine Hydrochloride 47
Lidocaine Hydrochloride 46
Exemestane 46
Potassium Chloride 46
Empagliflozin 46
Hydrocortisone 45
Anastrozole 45
Adalimumab 45
Ribociclib 44
Doxorubicin 43
Pertuzumab 43
Clopidogrel 42
Oxygen 42
Clavulanic Acid 42
Pomalidomide 42
Tenofovir Alafenamide 41
Ruxolitinib 41
Ibrutinib 41
Rivaroxaban 41
Abemaciclib 40
Atorvastatin 40
Ropivacaine Hydrochloride 40
Sulfamethoxazole 39
Bendamustine Hydrochloride 39
Carfilzomib 39
Trimethoprim 39
Pemetrexed Disodium 38
Propofol 38
Palbociclib 38
Linezolid 38
Metformin Hydrochloride 38
Ifosfamide 38
Cyclophosphamide Monohydrate 37
Dexamethasone Acetate 37
Emtricitabine 37

New drugs in trials

The list below features the new substances involved to ongoing clinical trials.

#1 VMX-C001

Clinical trials are studying VMX-C001 in people who take a Factor Xa direct oral anticoagulant and need urgent surgery or another high-bleeding-risk procedure.

4 weeks ago
#2 LIPASE

Clinical trials are investigating LIPASE, including a new lipase product compared with pancrelipase.

4 weeks ago
#3 TRIACYLGLYCEROL LIPASE

Clinical trials of TRIACYLGLYCEROL LIPASE are studying a new lipase treatment in adults with exocrine pancreatic insufficiency.

4 weeks ago
#4 IMA401

Clinical trials are investigating IMA401 in patients with recurrent and/or refractory solid tumors.

4 weeks ago
#5 ALLERGEN EXTRACTS

Clinical trials are studying BLOMIA TROPICALIS POLYMERIZED EXTRACT as part of a vaccine for dust mite and Blomia tropicalis allergy.

4 weeks ago
#6 AUR200

Clinical trials are investigating AUR200 in people with generalized myasthenia gravis.

4 weeks ago

Drugs starting by r

  • 1 

    Rugonersen

    ,

    Rugonersen, a novel drug developed by F. Hoffmann-La Roche Ltd, is currently being studied in clinical trials for the treatment of Angelman Syndrome (AS). This open-label, multicenter study aims to assess the safety, tolerability, and effectiveness of Rugonersen in patients with AS. The trial involves multiple phases, including a Multiple Ascending Dose part, a Long-Term Extension part, and an Optional Open-Label Extension part, to thoroughly evaluate the drug’s potential benefits for individuals with this rare genetic disorder.

    Related diseases and areas:

  • 2 

    Rupatadine

    , ,

    Clinical trials investigating Rupatadine are included in studies of allergic rhinitis, allergic rhinoconjunctivitis, and epidermolysis bullosa. These trials look at treatment effect, safety, and symptom control in different patient groups, including adolescents, adults, and children with severe skin disease. Some studies use Rupatadine as a comparator or supportive treatment within larger trial plans.

    Related diseases and areas:

  • 1 

    Rusfertide

    ,

    Clinical trials are investigating Rusfertide in people with polycythemia vera. The main goal is to see whether it can help maintain hematocrit control and how well it works compared with placebo. This article focuses on the study design, phase, participants, and outcomes being measured.

    Related diseases and areas:

  • 41 

    Ruxolitinib

    , , , , , , ,

    Clinical trials are investigating Ruxolitinib in many different patient groups, including people with skin, blood, immune, and cancer-related conditions. These studies look at safety, effectiveness, and response measures in children and adults across several trial phases.

    Related diseases and areas:

  • 1 

    Ruxotemitide

    ,

    This article discusses the ongoing clinical trial of Ruxotemitide (also known as LTX-315) in combination with pembrolizumab for patients with advanced melanoma. The study, called NeoLIPA, aims to evaluate the effectiveness and safety of this treatment approach in patients with resectable stage III-IV melanoma before surgery. We’ll explore the trial’s objectives, eligibility criteria, and potential outcomes for patients with this serious skin cancer.

    Related diseases and areas:

  • 2 

    Ruzasvir

    ,

    Clinical trials are studying Ruzasvir in people with chronic hepatitis C virus (HCV) infection. These trials are looking at safety, tolerability, and how well Ruzasvir-based treatment works, including in combination with other antiviral drugs and compared with standard treatment.

    Related diseases and areas: